Please Wait.....
Report
India Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Parenteral, Topical, Others), By Form (Tablets, Capsules, Injections, Others), By Source (Contract Manufacturing Organizations v/s In-house), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), By Application (Neurology, Oncology, Cardiovascular Diseases, Diabetes, Anti-Inflammatory Diseases, Others), By Region, Competition, Forecast & Opportunities, 2018-2028F
Market Report I 2022-07-01 I 73 Pages I TechSci Research
India generic drugs market stood at USD 24.53 Billion in 2022 and is expected to grow at a steady CAGR of 6.97% during the forecast period.
The growing prevalence of chronic diseases such as diabetes, cardiovascular disease, etc., and sedentary lifestyle propel market growth. The expanding geriatric population is contributing to the market growth as the comorbidities are more in the old population, thereby needing proper medications with the easiest route for drug administration. In developing countries like India, government bodies and other regulatory bodies have encouraged manufacturers to launch effective generic drugs supporting market growth. The introduction of 3-D printing technology helps in manufacturing generic drugs with varying release dates and tastes and is expected to propel market growth.
The short expiration and gap between re-filing of the new drug encourages various companies to produce generic drugs owing to rise in competition which further reduces the generic medication prices. Enhancing accessibility to healthcare services and growing healthcare awareness among the public drive market growth. Several initiatives are undertaken by government bodies towards awareness of the availability of generics like Pradhan Mantri Bhartiya and Jan Aushadi Yojana have become the highlight, offering quality medicines at affordable prices to the people. This scheme is currently running in each state of India with its high popularity among the people with average to low-income categories providing the public access to medications.
The India generic drugs market is segmented based on type, mode of drug delivery, form, source, distribution channel, application, and region. Based on type, the market can be split into small molecule generics and biosimilars. Small molecule generic drugs held the largest market share of 70.01% in 2022. This is due to the low cost of generic drugs compared to branded drugs and affordability to the large segment of patients from middle to low-income families.
The significant market players operating in the India generic drugs market include Sun Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited., Cipla Limited, Lupin Limited, Piramal Group, Glenmark Pharmaceuticals Limited, Biocon Limited, Dr. Reddy's Laboratories Limited, Aurobindo Pharma Limited.
Years considered for this report:
Historical Years: 2018-2021
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2024-2028
Objective of the Study:
- To analyze the historical growth of the market size of India generic drugs market from 2018 to 2021.
- To estimate and forecast the market size of India generic drugs market from 2023 to 2028 and growth rate until 2028.
- To classify and forecast India generic drugs market based on type, mode of drug delivery, form, source, distribution channel, application, regional distribution, and competitive landscape.
- To identify dominant region or segment in the India generic drugs market.
- To identify drivers and challenges for India generic drugs market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India generic drugs market.
- To identify and analyze the profile of leading players operating in India generic drugs market.
- To identify key sustainable strategies adopted by market players in India generic drugs market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of generic drugs manufacturing companies across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the vendors which could not be identified due to the limitations of secondary research.
TechSci Research calculated the India generic drugs market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.
Key Target Audience:
- Generic drugs manufacturing companies/partners
- End-users
- Government bodies such as regulating authorities and policy makers
- Organizations, industry associations, forums and alliances related to generic drugs
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as generic drugs manufacturing companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, India generic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- India Generic Drugs Market, By Type:
o Small Molecule Generics
o Biosimilars
- India Generic Drugs Market, By Mode of Drug Delivery:
o Oral
o Topical
o Parenteral
o Others
- India Generic Drugs Market, By Form:
o Tablets
o Capsule
o Injection
o Others
- India Generic Drugs Market, By Source:
o Contract Manufacturing Organizations
o In- House
- India Generic Drugs Market, By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o Others
- India Generic Drugs Market, By Application:
o Neurology
o Oncology
o Cardiovascular Diseases
o Diabetes
o Anti-Inflammatory
o Others
- India Generic Drugs Market, By Region:
o North
o South
o West
o East
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in India generic drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on India Generic Drugs Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness
5.2. Preference, By Mode of Purchase
5.3. Demand, By Therapeutic Area
5.4. Sources of Information
6. India Generic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Small Molecule Generics v/s Biosimilars)
6.2.2. By Mode of Drug Delivery (Oral, Parenteral, Topical, Others)
6.2.3. By Form (Tablets, Capsules, Injections, Others)
6.2.4. By Source (Contract Manufacturing Organizations v/s In-House Manufacturing)
6.2.5. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others)
6.2.6. By Application (Cardiovascular Diseases, Diabetes, Oncology, Neurology, Anti-Inflammatory Diseases, Others)
6.2.7. By Region
6.2.7.1. By States (Top 3 States)
6.2.8. By Company (2022)
6.3. Product Market Map
7. India Small Molecule Generic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mode of Drug Delivery
7.2.2. By Form
7.2.3. By Source
7.2.4. By Distribution Channel
7.2.5. By Application
8. India Biosimilar Generic Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mode of Drug Delivery
8.2.2. By Form
8.2.3. By Source
8.2.4. By Distribution Channel
8.2.5. By Application
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Policy & Regulatory Landscape
12. India Economic Profile
13. Competitive Landscape
13.1. Competition Outlook
13.2. Company Profiles
13.2.1. Sun Pharmaceutical Industries Limited
13.2.2. Torrent Pharmaceuticals Limited
13.2.3. Cipla Limited
13.2.4. Lupin Limited
13.2.5. Piramal Group
13.2.6. Glenmark Pharmaceuticals Limited
13.2.7. Biocon Limited
13.2.8. Dr. Reddy's Laboratories Limited
13.2.9. Aurobindo Pharma Limited
13.2.10. Teva Pharmaceuticals Limited
14. Strategic Recommendations
(Note: The companies list can be customized based on the client requirements.)
Notes: The data given for any year represents the market during the period, i.e., 1st April of the previous year to 31st March of that year. eg: For 2023E, the data represents the period, 1st April 2022 to 31st March 2023.
Figure 1: India Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 2: India Generic Drugs Market Share, By Type, By Value, 2018-2028F
Figure 3: India Generic Drugs Market Share, By Mode of Drug Delivery, By Value, 2018-2028F
Figure 4: India Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 5: India Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 6: India Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 7: India Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 8: India Generic Drugs Market Share, By Region, By Value, 2018-2028F
Figure 9: South India Generic Drugs Market Share, By State, By Value, 2018-2028F
Figure 10: North India Generic Drugs Market Share, By State, By Value, 2018-2028F
Figure 11: West India Generic Drugs Market Share, By State, By Value, 2018-2028F
Figure 12: East India Generic Drugs Market Share, By State, By Value, 2018-2028F
Figure 13: India Generic Drugs Market Share, By Company, By Value, 2022
Figure 14: India Generic Drugs Market Map, By Type, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 15: India Generic Drugs Market Map, By Mode of Drug Delivery, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 16: India Generic Drugs Market Map, By Form, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 17: India Generic Drugs Market Map, By Source, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 18: India Generic Drugs Market Map, By Distribution Channel, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 19: India Generic Drugs Market Map, By Application, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 20: India Generic Drugs Market Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2021
Figure 21: India Small Molecule Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 22: India Small Molecule Generic Drugs Market Share, By Mode of Drug Delivery, By Value, 2018-2028F
Figure 23: India Small Molecule Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 24: India Small Molecule Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 25: India Small Molecule Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 26: India Small Molecule Generic Drugs Market Share, By Application, By Value, 2018-2028F
Figure 27: India Biosimilar Generic Drugs Market Size, By Value (USD Billion), 2018-2028F
Figure 28: India Biosimilar Generic Drugs Market Share, By Mode of Drug Delivery, By Value, 2018-2028F
Figure 29: India Biosimilar Generic Drugs Market Share, By Form, By Value, 2018-2028F
Figure 30: India Biosimilar Generic Drugs Market Share, By Source, By Value, 2018-2028F
Figure 31: India Biosimilar Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028F
Figure 32: India Biosimilar Generic Drugs Market Share, By Application, By Value, 2018-2028F
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security